image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 4.17
-2.34 %
$ 426 M
Market Cap
14.38
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one DCGO stock under the worst case scenario is HIDDEN Compared to the current market price of 4.17 USD, DocGo Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one DCGO stock under the base case scenario is HIDDEN Compared to the current market price of 4.17 USD, DocGo Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one DCGO stock under the best case scenario is HIDDEN Compared to the current market price of 4.17 USD, DocGo Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
624 M REVENUE
41.72%
15.1 M OPERATING INCOME
-31.04%
6.86 M NET INCOME
-77.69%
-64.2 M OPERATING CASH FLOW
-222.45%
-29.9 M INVESTING CASH FLOW
22.28%
1.12 M FINANCING CASH FLOW
118.10%
139 M REVENUE
-15.92%
10.1 M OPERATING INCOME
-0.12%
4.55 M NET INCOME
-22.41%
31 M OPERATING CASH FLOW
-16.25%
-1.51 M INVESTING CASH FLOW
27.58%
-7.35 M FINANCING CASH FLOW
8.88%
Balance Sheet DocGo Inc.
image
Current Assets 339 M
Cash & Short-Term Investments 59.3 M
Receivables 262 M
Other Current Assets 17.5 M
Non-Current Assets 152 M
Long-Term Investments 554 K
PP&E 38.4 M
Other Non-Current Assets 113 M
Current Liabilities 170 M
Accounts Payable 19.8 M
Short-Term Debt 31.3 M
Other Current Liabilities 119 M
Non-Current Liabilities 15.2 M
Long-Term Debt 15.2 M
Other Non-Current Liabilities 0
EFFICIENCY
Earnings Waterfall DocGo Inc.
image
Revenue 624 M
Cost Of Revenue 429 M
Gross Profit 195 M
Operating Expenses 180 M
Operating Income 15.1 M
Other Expenses 8.2 M
Net Income 6.86 M
RATIOS
31.30% GROSS MARGIN
31.30%
2.41% OPERATING MARGIN
2.41%
1.10% NET MARGIN
1.10%
2.28% ROE
2.28%
1.40% ROA
1.40%
2.85% ROIC
2.85%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DocGo Inc.
image
Net Income 6.86 M
Depreciation & Amortization 16.4 M
Capital Expenditures -10.1 M
Stock-Based Compensation 21 M
Change in Working Capital -113 M
Others 55.8 M
Free Cash Flow -74.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DocGo Inc.
image
Wall Street analysts predict an average 1-year price target for DCGO of $8 , with forecasts ranging from a low of $5 to a high of $11 .
DCGO Lowest Price Target Wall Street Target
5 USD 19.90%
DCGO Average Price Target Wall Street Target
8 USD 91.85%
DCGO Highest Price Target Wall Street Target
11 USD 163.79%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership DocGo Inc.
image
Sold
0-3 MONTHS
174 K USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
144 K USD 3
6-9 MONTHS
121 K USD 3
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Dec 17, 2024
Sell 71.6 K USD
Leite Etalvina
Director
- 16500
4.34 USD
1 month ago
Dec 16, 2024
Sell 103 K USD
Tendler Ely D
General Counsel and Secretary
- 23088
4.44 USD
8 months ago
May 14, 2024
Bought 34 K USD
Burdiek Michael J
Director
+ 10000
3.4 USD
8 months ago
May 13, 2024
Bought 31.3 K USD
Tendler Ely D
General Counsel and Secretary
+ 10000
3.13 USD
8 months ago
May 13, 2024
Bought 78.8 K USD
Bienstock Lee
Chief Executive Officer
+ 25000
3.15 USD
10 months ago
Mar 15, 2024
Bought 49.1 K USD
KATZ STEVEN
Director
+ 13500
3.64 USD
10 months ago
Mar 14, 2024
Bought 36.1 K USD
ROSENBERG NORMAN
CFO and Treasurer
+ 10000
3.61 USD
10 months ago
Mar 14, 2024
Bought 36.1 K USD
Burdiek Michael J
Director
+ 10000
3.61 USD
1 year ago
Nov 28, 2023
Sell 16.4 K USD
Sugrue Stephen
Chief Compliance Officer
- 2859
5.75 USD
1 year ago
Oct 16, 2023
Sell 9.82 K USD
Bienstock Lee
Chief Executive Officer
- 1667
5.89 USD
1 year ago
Oct 02, 2023
Sell 52.9 K USD
Tendler Ely D
General Counsel and Secretary
- 10000
5.29 USD
1 year ago
Sep 15, 2023
Sell 10.5 K USD
Bienstock Lee
Chief Executive Officer
- 1667
6.32 USD
1 year ago
Sep 15, 2023
Sell 59.1 K USD
Tendler Ely D
General Counsel and Secretary
- 10000
5.91 USD
1 year ago
Sep 01, 2023
Sell 18 K USD
Capone Anthony
Chief Executive Officer
- 2000
9 USD
1 year ago
Aug 22, 2023
Sell 87.5 K USD
Tendler Ely D
General Counsel and Secretary
- 10000
8.75 USD
1 year ago
Aug 16, 2023
Sell 17 K USD
Bienstock Lee
President & COO
- 1667
10.19 USD
1 year ago
Aug 16, 2023
Sell 150 K USD
Capone Anthony
Chief Executive Officer
- 15000
10.01 USD
1 year ago
Aug 14, 2023
Sell 508 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 50000
10.15 USD
1 year ago
Aug 15, 2023
Sell 816 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 79029
10.33 USD
1 year ago
Jun 08, 2023
Sell 51.3 K USD
Capone Anthony
Chief Executive Officer
- 5400
9.5 USD
1 year ago
May 30, 2023
Sell 147 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 16271
9.02 USD
1 year ago
May 31, 2023
Sell 202 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 22366
9.01 USD
1 year ago
Jun 01, 2023
Sell 385 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 42497
9.07 USD
1 year ago
May 23, 2023
Sell 69.2 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 7595
9.11 USD
1 year ago
May 24, 2023
Sell 366 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 40000
9.14 USD
1 year ago
May 25, 2023
Sell 2.72 K USD
Oberholzer Adriaan Stephanus
See Remarks
- 300
9.07 USD
1 year ago
May 16, 2023
Sell 513 K USD
TRAVERS JAMES M
Director
- 60000
8.55 USD
1 year ago
May 17, 2023
Sell 553 K USD
TRAVERS JAMES M
Director
- 65000
8.51 USD
7. News
DocGo Announces Upcoming Participation at Needham Annual Growth Conference NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will hold a fireside chat at the Needham Annual Growth Conference on Wednesday, January 15th at 12:45 – 1:25 PM Eastern Time, and will be participating in 1x1 meetings at this event. A webcast of the fireside chat will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. businesswire.com - 1 week ago
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced an expanded partnership with SHL Telemedicine (NASDAQ: SHLT) to integrate the SmartHeart® portable 12-lead ECG device across DocGo mobile health care units. This expanded collaboration, initially launched in the New York-New Jersey area, will now bring advanced cardiovascular diagnostics to patients' homes and underserved communities i. businesswire.com - 1 month ago
DocGo Secures Two-Year Transportation Contract Renewal with Major Tennessee Healthcare System NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary signed a two-year renewal of its contract with a major Tennessee healthcare system. This renewal, building on a six-year partnership, highlights the Company's reliability in delivering efficient and high-quality medical transportation services. Under the renewed agreement, Ambulnz by DocGo will continue prov. businesswire.com - 1 month ago
DocGo Signs Contract in Mississippi with Major Hospital System to Provide Adult and Pediatric Remote Cardiac Monitoring Services NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced that its Cardiac RMS subsidiary has signed a new contract with one of the largest hospital systems in Mississippi. Under the agreement, in early 2025 Cardiac RMS by DocGo is scheduled to begin providing remote monitoring for nearly 3,000 patients with cardiac implantable electronic devices (“CIEDs”). This new contract marks Cardiac RMS. businesswire.com - 1 month ago
DocGo's EMS Direct Signs Two-Year Contract to Provide Medical Transportation for a Leading Health and Hospital System in Fort Worth NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced a new contract for ambulance transport services with one of the largest health and hospital systems in North Texas. Under this contract, DocGo's subsidiary EMS Direct is providing Basic Life Support, Advanced Life Support, and Critical Care transportation services to Fort Worth facilities. This agreement was signed and operationalized. businesswire.com - 1 month ago
DocGo Announces Participation at Three Upcoming Investor Conferences NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in November: Southwest Ideas Conference (November 20th) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday November 20th at 5:10 PM ET. A webcast of the event will be available on the investor relations section of Do. businesswire.com - 2 months ago
DocGo, Inc. (DCGO) Q3 2024 Earnings Call Transcript DocGo, Inc. (NASDAQ:DCGO ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Michael Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Pito Chickering - Deutsche Bank Ryan MacDonald - Needham Operator Welcome to DocGo, Inc. Third Quarter 2024 Earnings Call. [Operator Instructions]. seekingalpha.com - 2 months ago
DocGo Inc. (DCGO) Tops Q3 Earnings Estimates DocGo Inc. (DCGO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.05 per share a year ago. zacks.com - 2 months ago
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm NEW YORK , Oct. 31, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives were insufficient for thoroughly examining and verifying the professional and educational backgrounds of applicants; (ii) this inadequacy heightened the risk of disruptive changes in executive leadership; (iii) contrary to what it had communicated to investors, DocGo had overestimated the effectiveness of its mobile health and medical transportation services, which were key components of the Relocation Contract; (iv) all these issues, once disclosed, were likely to expose DocGo to considerable reputational and/or regulatory examination, adversely affecting the company's financial health and future outlook; and (v) consequently, the company's public declarations were inaccurate and misleading throughout the times in question. prnewswire.com - 2 months ago
DocGo to Announce Third Quarter 2024 Results on Thursday, November 7, 2024 NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the third quarter ended September 30, 2024 after the markets close on Thursday, November 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, November 7, 2024 5:00 p.m. ET 1-800-71. businesswire.com - 2 months ago
Ambulnz by DocGo and Bayhealth Renew Partnership in Delaware, Extending Contract for Three Years NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has renewed its contract with Bayhealth – central and southern Delaware's largest healthcare system – for an additional three-year term. This extension is a testament to Ambulnz's proven success supporting Bayhealth with timely, dependable non-emergency transportation services. The Company anticipates comple. businesswire.com - 3 months ago
DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jef. businesswire.com - 3 months ago
8. Profile Summary

DocGo Inc. DCGO

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 426 M
Dividend Yield 0.00%
Description DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Contact 35 West 35th Street, New York, NY, 10001 https://www.docgo.com
IPO Date Dec. 17, 2020
Employees 2915
Officers Mr. Norman Rosenberg Treasurer & Chief Financial Officer Ms. Rosemarie Milano Vice President of Human Resources Dr. James Powell M.D. Chief Executive Officer of Clinical Practice Group & Member of Medical Advisory Board Mr. Ely D. Tendler J.D. General Counsel, Secretary & Director Mr. Andre Oberholzer CPA Executive Vice President of Strategy Ms. Vrenely Munoz Chief Revenue Officer Mr. Lee Bienstock Chief Executive Officer & Director Mr. Stephen Sugrue Chief Compliance Officer Mr. Eiwe Lingefors Chief Information Officer Mr. Mike Cole Vice President of Investor Relations